Genpact (G) Could Be 11% Undervalued After Its Recent Run

Genpact (G) stock has been drawing fresh attention after recent trading performance, with the shares last closing at $37.59. Investors are weighing this move against the company’s return profile and fundamental business trends.

See our latest analysis for Genpact.

The recent 20.3% 1 month share price return and 20.5% 3 month share price return suggest short term momentum for Genpact, although the 1 year total shareholder return has declined 15.8% and the 5 year total shareholder return has declined 22.4%.

If you are considering how Genpact fits alongside other opportunities in tech enabled services, it can be useful to scan 20 top founder-led companies

After Genpact’s latest move, the stock trades below both analyst targets and one intrinsic value estimate, which point in different directions. Does that gap flag mispricing, or does it simply mark the new normal for this business?

Most Popular Narrative: 10.9% Undervalued

The most followed narrative currently places Genpact's fair value at $42.18, which is above the last close at $37.59. That gap rests on specific assumptions about how AI driven services reshape the business mix over time.

Accelerated client adoption of Genpact's Advanced Technology Solutions particularly in data and AI should drive higher growth and improved margins, as these offerings deliver over twice the revenue per headcount versus legacy services and are expanding at over twice the company's overall rate, pointing toward robust long-term revenue and margin expansion.

Read the complete narrative. Read the complete narrative.

Want to see what kind of revenue mix, margin profile, and earnings path are being baked in to support that fair value gap and the projected return profile for Genpact?

Result: Fair Value of $42.18 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there is still a risk that slowing legacy BPO demand and tougher competition in AI rich services could limit the extent to which the Genpact narrative plays out.

Find out about the key risks to this Genpact narrative.

Next Steps

With Genpact generating both concern and optimism, it makes sense to move quickly and review the full picture for yourself with 5 key rewards and 1 important warning sign

Looking for more Genpact investment ideas?

If you like what you see with Genpact but want a stronger shortlist, use these focused stock ideas so you do not miss other compelling opportunities.

• Target reliable income opportunities by reviewing companies described as 12 dividend fortresses that may suit a portfolio focused on higher yields.
• Spot potential value candidates early by checking the screener containing 18 high quality undiscovered gems and see which stocks the market may be overlooking.
• Reduce potential downside risk by focusing on businesses within the 74 resilient stocks with low risk scores that emphasise resilience and balance sheet strength.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com